Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

Cancer chemotherapy reports ·Vol. 57 ·No. 3 ·1973-00-00 ·Pages 299-304

Kline I, Gang M, Woodman RJ, Cysyk RL, Venditti JM

Abstract

暂无摘要

MeSH Terms

Acetylcysteine/pharmacology Animals Antineoplastic Agents/therapeutic use,toxicity Cyclic P-Oxides/therapeutic use,toxicity Drug Synergism Female Hemorrhage/chemically induced Leukemia L1210/drug therapy Male Mice Mice, Inbred C57BL Mice, Inbred DBA Neoplasm Transplantation Organophosphorus Compounds/therapeutic use,toxicity Oxazines/therapeutic use,toxicity Time Factors Transplantation, Homologous Urinary Bladder Diseases/chemically induced

Chemicals

Antineoplastic Agents Cyclic P-Oxides Organophosphorus Compounds Oxazines Acetylcysteine

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Kline I

Gang M

Woodman R J

Cysyk R L

Venditti J M

Article Info

Journal

Cancer chemotherapy reports

Abbr.

Cancer Chemother Rep

ISSN

0069-0112

Published

1973-00-00

Pages

299-304

Language

English

Region

United States

NLM ID

7607105

Subset

External Links

PubMed source

Analysis Services

Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

Contact

WeChat Official Account